GlaxoSmithKline Pharma, celebrating 100 years in India, is shifting to a specialty-focused model by entering the oncology market and expanding its preventive healthcare through adult vaccines. With 30 crore prescriptions annually, GSK aims to innovate and grow its portfolio, highlighting price strategies catering to a broad market range, from general medicines to high-value therapies.
GlaxoSmithKline Pharma to enter oncology market, launch adult vax
Categories:
Related Post
Watch: Bangladesh make a mess of a run out chance against IndiaWatch: Bangladesh make a mess of a run out chance against India
Bangladesh ended their India tour winless, losing both Test and T20I series. India’s extraordinary performance in the third T20I saw them score a record 297/6, thanks to Sanju Samson’s century.
Samson slams maiden T20I century, becomes second fastest IndianSamson slams maiden T20I century, becomes second fastest Indian
Struggling Sanju Samson regained his form by scoring his maiden T20I century in just 40 balls against Bangladesh in Hyderabad. This performance surpasses Suryakumar Yadav’s previous record and brings Samson
‘Going to be painful’: Venezuelan expert sounds alarm about what’s next if sanctuary city policies continue‘Going to be painful’: Venezuelan expert sounds alarm about what’s next if sanctuary city policies continue
An expert on the international criminal group Tren de Aragua (TdA) is warning that if sanctuary city and state policies are allowed to continue, the U.S. will soon be facing